Telstra – Buy Signal
Telstra Corporation is under Algo Engine buy conditions.

Telstra Corporation is under Algo Engine buy conditions.
iShares Global Healthcare is now under Algo Engine buy conditions and has been added to our ASX ETF model.
The fund aims to provide investors with the performance of the S&P Global 1200 Healthcare Sector IndexTM, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or small-capitalisation stocks.
VanEck Vectors Global Health Leaders is under Algo Engine buy conditions.
HLTH invests in a diversified portfolio of leading international developed markets (ex-Australia) companies with the best growth at a reasonable price (GARP) attributes from the global healthcare sector with the aim of providing investment returns, before fees and other costs, which track the
performance of the Index.
In case you missed it, you can watch last night’s webinar here.
Tonight’s webinar will be available for members and non-members to access. Join us to find out what stocks we’re buying and selling in today’s market.
You can use this link to watch it.
The start time is 8pm NSW time.
iShares S&P/ASX 20 is now under Algo Engine buy conditions and has been added to our iShares ETF model portfolio.
Wesfarmers is under Algo Engine buy conditions and is a current holding in our model portfolio.
Wesfarmers now holds 19.3% of Australian Pharmaceutical Industries. The acquisition has less than two weeks left in confirmatory due diligence. The battle between Sigma and Wesfarmers for the API business and final offers will be worth watching.
Accumulate.
Rio Tinto is under Algo Engine buy conditions.
Treasury Wine Estates is under Algo Engine buy conditions.
TWE continues to adjust to a post pandemic/post Chinese tariff environment. FY21 EBIT of $510 exceeded market expectations. After a number of years of disappointment for TWE in this region, we see America’s division accelerating growth into FY22.
FY22 EBIT growth is forecast to be in the mid to high single-digit range.
Or start a free thirty day trial for our full service, which includes our ASX Research.